Skip to Content

Vanderbilt-Ingram Cancer CenterVanderbilt-Ingram Cancer Center

 
Jeremy L. Warner

Jeremy L. Warner, M.D., M.S.

Assistant Professor of Medicine and Biomedical Informatics
Hematologist/Oncologist

  • Appointments
    615-936-8422
    Physicians: 1-877-936-8422
  • Clinical Trials Information
  • Other Telephone Numbers
    Division of Hematology/Oncology
    (615) 322-4967

    Office
    615-936-3524
  • Faxes
    Division of Hematology/Oncology Fax
    (615) 343-7602
    Office Fax
    615-343-7602
    Clinic Fax
    615-936-1812
  • Addresses
    Clinic
    Vanderbilt University Medical Center
    1301 Medical Center Drive
    Suite 3903
    Nashville, TN 37232-5505

    Division of Hematology/Oncology
    2220 Pierce Ave, 777 PRB
    Nashville, TN 37232-6307
    Website

    Office
    Vanderbilt University Medical Center
    2220 Pierce Avenue
    777 PRB
    Nashville, TN 37232-6307
Profile

Jeremy Warner joined the faculty at Vanderbilt University in August 2012 as an Assistant Professor with a primary appointment in Hematology/Oncology, and secondary appointment in Biomedical Informatics. His clinical focus is in the area of lymphoid neoplasms, which are diseases of the blood, lymph nodes, and blood-forming organs.
Read more...

Jeremy Warner joined the faculty at Vanderbilt University in August 2012 as an Assistant Professor with a primary appointment in Hematology/Oncology, and secondary appointment in Biomedical Informatics. His clinical focus is in the area of lymphoid neoplasms, which are diseases of the blood, lymph nodes, and blood-forming organs. His research interests are primarily focused on clinical and translational cancer informatics, specifically: (1) natural language processing to extract clinical facts from narrative oncology texts; (2) visualization of the dissemination and uptake of new oncology treatments and technology innovations; and (3) high-dimensional data visual analytics. He is the current Chair of the American Society of Clinical Oncology (ASCO)'s Health Information Technology Work Group, which focuses on bringing new and innovative technologies to the routine care of cancer patients. He is also one of two ASCO representatives to the American Joint Committee on Cancer, the organization responsible for developing and updating cancer staging rules.

Education
  • B.S. in Electrical Engineering at Massachusetts Institute of Technology
  • M.S. in Electrical and Computer Engineering at University of California, San Diego
  • M.D. at Boston University School of Medicine
  • Internship at University of California, San Francisco
  • Residency at University of California, San Francisco
  • Fellowship in Hematology/Oncology at Beth Israel Deaconess Medical Center, Harvard Medical School
Publications
  • Warner JL, Cowan AJ, Hall AC, Yang PC. HemOnc.org: A Collaborative Online Knowledge Platform for Oncology Professionals. J Oncol Pract [print-electronic]. 2015 May; 11(3): e336-50. PMID: 25736385, PII: JOP.2014.001511, DOI: 10.1200/JOP.2014.001511, ISSN: 1935-469X.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/25736385.
  • Warner JL, Maddux SE, Hughes KS, Krauss JC, Yu PP, Shulman LN, Mayer DK, Hogarth M, Shafarman M, Stover Fiscalini A, Esserman L, Alschuler L, Koromia GA, Gonzaga Z, Ambinder EP. Development, implementation, and initial evaluation of a foundational open interoperability standard for oncology treatment planning and summarization. J Am Med Inform Assoc [print-electronic]. 2015 May; 22(3): 577-86. PMID: 25604811, PII: ocu015, DOI: 10.1093/jamia/ocu015, ISSN: 1527-974X.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/25604811.
  • Warner JL, Denny JC, Kreda DA, Alterovitz G. Seeing the forest through the trees: uncovering phenomic complexity through interactive network visualization. J Am Med Inform Assoc [print-electronic]. 2015 Mar; 22(2): 324-9. PMID: 25336590, PII: amiajnl-2014-002965, DOI: 10.1136/amiajnl-2014-002965, ISSN: 1527-974X.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/25336590.
  • Meador CB, Micheel CM, Levy MA, Lovly CM, Horn L, Warner JL, Johnson DB, Zhao Z, Anderson IA, Sosman JA, Vnencak-Jones CL, Dahlman KB, Pao W. Beyond histology: translating tumor genotypes into clinically effective targeted therapies. Clin. Cancer Res [print-electronic]. 2014 May 5/1/2014; 20(9): 2264-75. PMID: 24599935, PMCID: PMC4008689, PII: 1078-0432.CCR-13-1591, DOI: 10.1158/1078-0432.CCR-13-1591, ISSN: 1078-0432.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/24599935.
  • Naser R, Roberts J, Salter T, Warner JL, Levy M. An informatics-enabled approach for detection of new tumor registry cases. J Registry Manag. 2014; 41(1): 19-23. PMID: 24893184, ISSN: 1945-6123.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/24893184.
  • Warner JL, Zollanvari A, Ding Q, Zhang P, Snyder GM, Alterovitz G. Temporal phenome analysis of a large electronic health record cohort enables identification of hospital-acquired complications. J Am Med Inform Assoc [print-electronic]. 2013 Dec; 20(e2): e281-7. PMID: 23907284, PMCID: PMC3861919, PII: amiajnl-2013-001861, DOI: 10.1136/amiajnl-2013-001861, ISSN: 1527-974X.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/23907284.
  • Warner JL, Yang P, Alterovitz G. Reversal of medical practices [letter]. Mayo Clin. Proc. 2013 Oct; 88(10): 1182-3. PMID: 24079691, PII: S0025-6196(13)00728-3, DOI: 10.1016/j.mayocp.2013.08.010, ISSN: 1942-5546.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/24079691.
  • Warner JL, Alterovitz G, Bodio K, Joyce RM. External phenome analysis enables a rational federated query strategy to detect changing rates of treatment-related complications associated with multiple myeloma. J Am Med Inform Assoc [print-electronic]. 2013 Jul; 20(4): 696-9. PMID: 23515788, PMCID: PMC3721159, PII: amiajnl-2012-001355, DOI: 10.1136/amiajnl-2012-001355, ISSN: 1527-974X.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/23515788.
  • Warner JL, Anick P, Drews RE. Physician inter-annotator agreement in the Quality Oncology Practice Initiative manual abstraction task. J Oncol Pract. 2013 May; 9(3): e96-102. PMID: 23942509, PMCID: PMC3651579, PII: 9/3/e96, DOI: 10.1200/JOP.2013.000931, ISSN: 1935-469X.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/23942509.
  • Warner J, Hochberg E. Where is the EHR in oncology?. J Natl Compr Canc Netw. 2012 May; 10(5): 584-8. PMID: 22570289, PII: 10/5/584, ISSN: 1540-1413.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/22570289.
  • Warner JL, Alterovitz G. Phenome based analysis as a means for discovering context dependent clinical reference ranges. AMIA Annu Symp Proc [print-electronic]. 2012; 2012: 1441-9. PMID: 23304424, PMCID: PMC3540498, ISSN: 1942-597X.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/23304424.
  • Selby KJ, Warner J, Klempner S, Konstantinopoulos PA, Hecht JL. Anti-Yo antibody associated with occult fallopian tube carcinoma. Int. J. Gynecol. Pathol. 2011 Nov; 30(6): 536-8. PMID: 21979588, PII: 00004347-201111000-00004, DOI: 10.1097/PGP.0b013e3182237ca6, ISSN: 1538-7151.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/21979588.
  • Warner JL, Anick P, Hong P, Xue N. Natural language processing and the oncologic history: is there a match?. J Oncol Pract. 2011 Jul; 7(4): e15-9. PMID: 22043196, PMCID: PMC3140455, PII: 3706159, DOI: 10.1200/JOP.2011.000240, ISSN: 1935-469X.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/22043196.
  • Britt GJ, Gaughan EM, Nguyen KS, Warner JL, Goldstein MA, Huberman MS, Costa DB. Case series of treatment approaches in fit nonagenarians with stage IV non-small-cell lung cancer. J Thorac Dis. 2011 Jun; 3(2): 141-3. PMID: 22263078, PMCID: PMC3256509, PII: jtd-03-02-141, DOI: 10.3978/j.issn.2072-1439.2011.03.02, ISSN: 2077-6624.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/22263078.
  • Yeo WL, Riely GJ, Yeap BY, Lau MW, Warner JL, Bodio K, Huberman MS, Kris MG, Tenen DG, Pao W, Kobayashi S, Costa DB. Erlotinib at a dose of 25 mg daily for non-small cell lung cancers with EGFR mutations. J Thorac Oncol. 2010 Jul; 5(7): 1048-53. PMID: 20512075, PMCID: PMC2893286, DOI: 10.1097/JTO.0b013e3181dd1386, ISSN: 1556-1380.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/20512075.
  • Warner JL, Najarian RM, Tierney LM. Perspective: Uses and misuses of thresholds in diagnostic decision making. Acad Med. 2010 Mar; 85(3): 556-63. PMID: 20182138, PII: 00001888-201003000-00039, DOI: 10.1097/ACM.0b013e3181ccd59b, ISSN: 1938-808X.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/20182138.
  • Warner JL. Risk prediction versus diagnosis: preserving clinical nuance in a binary world [letter]. Ann. Intern. Med. 2009 Feb 2/3/2009; 150(3): 222; author reply 224. PMID: 19189919, PII: 150/3/222, ISSN: 1539-3704.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/19189919.
  • Wisco JJ, Rosene DL, Killiany RJ, Moss MB, Warfield SK, Egorova S, Wu Y, Liptak Z, Warner J, Guttmann CR. A rhesus monkey reference label atlas for template driven segmentation. J. Med. Primatol [print-electronic]. 2008 Oct; 37(5): 250-60. PMID: 18466282, PMCID: PMC2724263, PII: JMP288, DOI: 10.1111/j.1600-0684.2008.00288.x, ISSN: 0047-2565.
    Available from: http://www.ncbi.nlm.nih.gov/pubmed/18466282.